194 related articles for article (PubMed ID: 3911847)
21. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
Manasco PK; Pescovitz OH; Feuillan PP; Hench KD; Barnes KM; Jones J; Hill SC; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
[TBL] [Abstract][Full Text] [Related]
22. [Change in stature after pseudo-puberty early by 11ß hydroxylase deficiency in a girl of 7 years: report of a case and review of literature].
Latrech H; Gaouzi A
Pan Afr Med J; 2015; 20():162. PubMed ID: 26113905
[TBL] [Abstract][Full Text] [Related]
23. Modern medical therapy of congenital adrenal hyperplasia. A decade of experience.
Winter JS; Couch RM
Ann N Y Acad Sci; 1985; 458():165-73. PubMed ID: 3879120
[No Abstract] [Full Text] [Related]
24. From the National Institutes of Health.
Wyngaarden JB
JAMA; 1986 Sep; 256(9):1097. PubMed ID: 3525879
[No Abstract] [Full Text] [Related]
25. [Long-term therapy with delayed-action LHRH-antagonist decapeptyl depot in girls with precocious puberty. Results of an international multicenter study].
Sippell WG; Partsch CJ; Hümmelink R; Lorenzen F
Gynakologe; 1991 Apr; 24(2):108-13. PubMed ID: 1835952
[No Abstract] [Full Text] [Related]
26. Follow-up of children and young adults after GnRH-agonist therapy or central precocious puberty.
Feuillan PP; Jones JV; Barnes K; Klein KO; Cutler GB
J Endocrinol Invest; 2001 Oct; 24(9):734-6. PubMed ID: 11716160
[No Abstract] [Full Text] [Related]
27. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.
Comite F; Cassorla F; Barnes KM; Hench KD; Dwyer A; Skerda MC; Loriaux DL; Cutler GB; Pescovitz OH
JAMA; 1986 May; 255(19):2613-6. PubMed ID: 3084811
[TBL] [Abstract][Full Text] [Related]
28. Growth and pubertal development in patients with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency.
Hochberg Z; Schechter J; Benderly A; Leiberman E; Rosler A
Am J Dis Child; 1985 Aug; 139(8):771-6. PubMed ID: 3875277
[TBL] [Abstract][Full Text] [Related]
29. [Congenital adrenal hyperplasia apropos of 7 cases at the University Hospital Center of Dakar].
Fall M; Sarr M; Sy HS; Ba M; Ould Cheikh A; Diack Mbaye A; Diouf S; Diagne I
Dakar Med; 1989; 34(1-4):58-63. PubMed ID: 2491387
[TBL] [Abstract][Full Text] [Related]
30. Intranasal LH-RH analogue treatment of precocious puberty.
Koehler B; Koehler M; Osuch-Jaczewska R
Exp Clin Endocrinol; 1988 Mar; 92(3):252-6. PubMed ID: 3075552
[TBL] [Abstract][Full Text] [Related]
31. Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.
Laue L; Comite F; Hench K; Loriaux DL; Cutler GB; Pescovitz OH
Am J Dis Child; 1985 Nov; 139(11):1097-100. PubMed ID: 3933329
[TBL] [Abstract][Full Text] [Related]
32. Effect of deslorelin dose in the treatment of central precocious puberty.
Pescovitz OH; Barnes KM; Cutler GB
J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
[TBL] [Abstract][Full Text] [Related]
33. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
[TBL] [Abstract][Full Text] [Related]
34. Adult height in precocious puberty after long-term treatment with deslorelin.
Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
[TBL] [Abstract][Full Text] [Related]
35. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
Mansfield MJ; Rudlin CR; Crigler JF; Karol KA; Crawford JD; Boepple PA; Crowley WF
J Clin Endocrinol Metab; 1988 Jan; 66(1):3-9. PubMed ID: 2961786
[TBL] [Abstract][Full Text] [Related]
36. Boy with central precocious puberty probably due to a peripheral cause.
Sahana PK; Gopal Sankar KS; Sengupta N; Chattopadhyay K
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27256994
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin-releasing hormone analogues in the management of precocious puberty.
Spiliotis BE
Ann N Y Acad Sci; 2000; 900():429-34. PubMed ID: 10818433
[No Abstract] [Full Text] [Related]
38. The central issue in precocious puberty.
Bertelloni S; Baroncelli GI; Saggese G
J Pediatr; 1997 Nov; 131(5):786. PubMed ID: 9403669
[No Abstract] [Full Text] [Related]
39. [The significance and characteristics of the LHRH test in diagnosing precocious puberty development in girls: the stimulated LH/FSH quotient differentiates between central precocious puberty and premature thelarche].
Partsch CJ; Hümmelink R; Lorenzen F; Sippell WG
Monatsschr Kinderheilkd; 1989 May; 137(5):284-8. PubMed ID: 2525665
[TBL] [Abstract][Full Text] [Related]
40. [Pseudo- and central precocious puberty due to adrenogenital syndrome].
Pouw IS; Drop SL; Ladée-Levy JV; Slijper FM
Tijdschr Kindergeneeskd; 1986 Jun; 54(3):77-83. PubMed ID: 2944246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
